| PMP | pain management program; patient management program; patient medication profile; peripheral myelin p... |
|---|---|
| PP | diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa... |
| PPD | packs per day; paraphenylenediamine; percussion and postural drainage; permanent partial disability;... |
| PPP | pain perception profile; palatopharyngoplasty; palmoplantar pustulosis; pentose phosphate pathway; p... |
| PS | pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy... |
| core I protein, ubiquinol-cytochrome c reductase | <chemical> Member of the mitochondrial-protein-processing family; protein found in subunits of ubiquinol-cytochrome c reductase; amino acid sequence given in first source Synonym: core I protein, uccreductase (26 Jun 1999) |
|---|---|
| myelin basic protein | <protein> Major component of the myelin sheath in mammalian CNS. Used as an antigen will induce a allergic encephalitis, possibly a model for some neurodegenerative disorders. (18 Nov 1997) |
| myelin basic protein kinase | <enzyme> Protein from pig brain activates ATP-mg-dependent protein phosphatase; a protein tau kinase; a multisubstrate kinase; in texts written as f subscript a Registry number: EC 2.7.1.- Synonym: protein phosphatase activator fa, glycogen synthase kinase 3, protein kinase f(a), gsk-3, gsk-3alpha, kinase f(a), gsk-3beta, mds1 gene product, p63(samk), src-activated mbp kinase, p63(mapk) (26 Jun 1999) |
| corticosteroid-binding protein | <chemical> Chemical name: Transcortins (12 Dec 1998) |
| myelin p0 protein | A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. (12 Dec 1998) |
| myelin p2 protein | A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that p2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis (neuritis, experimental allergic), the peripheral nervous system counterpart of experimental allergic encephalomyelitis. (12 Dec 1998) |
| myelin protein A1 | An important protein in the central nervous system. Synonym: myelin protein A1. (05 Mar 2000) |
| myelin proteolipid protein | A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. (12 Dec 1998) |
| myeloblastic protein | See: human leukaemia-associated antigens. (05 Mar 2000) |
| myeloma protein | <haematology, oncology> The immunoglobulins and Bence Jones proteins secreted by myeloma cells. (18 Nov 1997) |
| myod protein | A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, myod appears to be related to fusion and terminal differentiation of the muscle cell. (12 Dec 1998) |
| C protein | <cell biology> Striated muscle thick filament associated proteins (140-150 kD) that show up in the C zone of the A band as 43nm transverse stripes. Structurally related to various other myosin binding proteins (twitchin, titin, myosin light chain kinase, skelemin, 86 kD protein, projectin, M protein). (18 Nov 1997) |
| myotonin-protein kinase | <enzyme> Has been sequenced Registry number: EC 2.7.- Synonym: mtpk, myotonin protein kinase (26 Jun 1999) |
| C-reactive protein | <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream. C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide. Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction. A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills. See: acute phase proteins (06 Oct 1997) |
| CRK4 protein kinase | <enzyme> From mouse, has 85% amino acid identity with xenopus m015 protein kinase; genbank x74145 Registry number: EC 2.7.10.- Synonym: crk4 pk (26 Jun 1999) |